HIF1A and hepatocellular carcinoma: It has been recently demonstrated that PI3K/Akt signaling pathway regulates VEGF and HIF-1α expression, and inhibitors targeting PI3K p110α decrease both VEGF expression and angiogenesis in HCC in vitro model [20].